INSIGHTS ON QUALITY ASSURANCE

• Why Biotech Leaders Can't Afford Delays In Document Review

  Document review is a hidden bottleneck in biopharma. Learn how inefficiencies in this critical process can delay drug development and what you can do to accelerate time to market.

• Cambrex Scientist Spotlight: Luigi Bellone

  Luigi Bellone, Head of Quality Assurance in Paullo, Milan, brings over 20 years of experience in quality assurance (QA), quality control (QC), and regulatory compliance within the pharmaceutical industry.

• Aggregate Analysis Of Semaglutide

  Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.

• Real-Time Monitoring Of Solvent Clearance By TFF In The ADC Process

  Raman spectroscopy revolutionizes ADC manufacturing by enabling real-time monitoring of solvent clearance. Discover how it enhances process control, ensures regulatory compliance, and supports the production of high-quality therapeutics.

• Wetting Recommendations For Successful Filter Integrity Testing

  1/12/2026

  Discover best practices for hydrophobic and hydrophilic filters, troubleshoot failures, and optimize wetting in stainless steel and single-use systems to ensure process reliability and product quality.

• How To Reduce Batch Loss In Biopharma Production

  12/12/2025

  Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.

• The Benefits Of Low Endotoxin Products

  6/16/2025

  Minimizing endotoxin contamination is vital in pharmaceutical manufacturing to protect patients from harmful reactions. Learn more about rigorously tested, low-endotoxin products designed for critical cleanroom and sterile applications.

• Navigating The Regulatory Space To Biosimilar Approval

  9/1/2025

  The biosimilar patent cliff is reshaping pharma, creating unprecedented opportunities for biotech and CDMOs. Explore expert regulatory support that can help you navigate this shift with confidence.

• The Rising Cost Of Product Recalls In Life Sciences

  9/2/2025

  Product recalls are becoming a major concern in life sciences. Learn why your company must act now to strengthen quality systems and reduce risk across pharmaceuticals, devices, and biologics.